期刊文献+

伊布利特转复老年心房颤动/心房扑动的观察与护理 被引量:2

下载PDF
导出
摘要 目的观察伊布利特在转复老年心房颤动/心房扑动中的有效性和安全性,总结围转复期的护理经验。方法选择28例持续时间<90 d的心房颤动/心房扑动老年患者,根据体质量静推伊布利特,密切观察转复过程中的心电、血压,比较不同病程长短对转复成功率的影响,并观察转复过程中的不良反应。结果持续90 d内,不同病程之间心房颤动/心房扑动转复成功率差别不大(P=1.000)。发生短阵室性心动过速4例,心室纤颤1例。结论对于老年心房颤动/心房扑动患者,伊布利特是相对安全有效的转复药物之一,严格把握适应证和禁忌证并严密观察能够减少不良反应的发生。
作者 王英
机构地区 解放军总医院
出处 《现代中西医结合杂志》 CAS 2010年第14期1792-1793,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

二级参考文献8

  • 1Miller MR, McNamara RL, Segal JB,et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a Meta analysis of clinical trials. J Fam Pract,2000,49:1033-1046.
  • 2Cropp Js, Antal EG, Talbert RL,et al. Ibutilide: a new class Ⅲ antiarrhythmic agent. Parmarcotherapy, 1997,17:1-9.
  • 3Lych JR, Baskin EP, Nutt EM, et al, Comparision of binding to rapidly activating delayed rectifier K channel, Ikr and effects on myocardial refractoriness for class Ⅲ antiarrythmic agents. J Cardiovasc Pharmacol, 1995,25:336-340.
  • 4Naccarelli GV, Lee KS, Gibson JK, et al. Electrophysiology and pharmacology of Ibutilide. Am J Cardiol,1996,78(8A): 12-16.
  • 5Baskin EP , Lynch JJ Jr. Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers. Pharmacol Exp Ther, 1998,285:135-142.
  • 6Ellenbogen KA, Stambler BS, Wood MA, et al . Efficacy of intravenous Ibutilide for rapid termination of atrial fibrillation and atril flutter: a dose-response study. J Am Coll Cardiol, 1996, 28: 130-136.
  • 7Gowdw RM, Punukollu G, Khan LA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther, 2003,10: 259-263.
  • 8Kowey PR, Vanderlugt JT, Luderer JR. Safety and risk/benefit analysis of Ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol , 1996,78 (suppl 8A): 46-52.

共引文献48

同被引文献7

  • 1张海澄,郭继鸿,方全,郑亚安,孙跃民,朱文青,万征,郭静萱,葛均波,韩少梅.静脉注射伊布利特与普罗帕酮转复心房颤动和扑动的多中心研究[J].中华医学杂志,2005,85(12):798-801. 被引量:43
  • 2Stambler BS,Wood MA,Ellenbogen KA,et al.Ibutilide Repeat Dose Study Investigators.Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation[J].Circulation,1996,94(7):1613-1621.
  • 3Nair M,George LK,Koshy SK.Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation[J].J Am Board Fam Med,2011,24(1):86-92.
  • 4Kafkas NV,Patsilinakos SP,Mertzanos GA,et al.Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter[J].Int J Cardiol,2007,118(3):321-325.
  • 5Fuster V,Ryden LE,Cannom DS,et al.2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American college of cardiology Foundation/American heart association task force on practice guidelines developed in partnership with the European society of cardiology and in collaboration with the European heart rhythm association and the heart rhythm society[J].Am Coll Cardiol,2011,57(11):101-198.
  • 6Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the task force for the management of atrial fibrillation of the european society of cardiology(ESC)[J].Eur Heart J,2010,31(19):2369-2429.
  • 7张海澄,佟光明.伊布利特临床应用经验与体会[J].临床心电学杂志,2008,17(1):14-15. 被引量:8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部